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The ongoing efforts by the French gov-
ernment to revamp its national research 
organizations and to redefine a national 
strategy for scientific innovation have 
many French researchers concerned. 
“There is an immense revolt in the scien-
tific research community. The government 
does not understand our institutions, and 
they are doing things that do not work,” 
says Isabelle Saint-Jean, President of the 
lobby group Let’s Save Research (Sau-
vons La Recherche), founded in 2004 dur-
ing the first round of government cuts to 
science. “I don’t think that scientists can 
be completely independent and should 
be living in an ivory tower. There is always 
political pressure, but I guess the way 
that the reforms are being conducted is 
not useful and are giving many research-
ers the impression that they are taking 
everything away at once,” says Mathieu 
Beraneck, a neurobiology postdoc at the 
Université Paris-Descartes.
Professors, postdocs, and students 
across France took to the streets in 
protest earlier this year, after President 
Nicolas Sarkozy announced his intention 
to dismantle CNRS (Centre Nationale de 
la Recherche Scientifique), a bastion of 
basic research, and remove its decision-
making capabilities. And in April this 
year, the French government announced 
plans to unite disparate research insti-
tutes into a new National Alliance for Life 
and Health Sciences (Alliance Nation-
ale pour les Sciences de la Vie et de la 
Santé). Compounding these sweeping 
changes is an ongoing reorganization of 
the university system that aims to make 
universities more autonomous with uni-
versity presidents now allowed to decide 
how much time scientists can spend on 
research versus teaching.
CNRS, INSERM, and ANR
The beleaguered CNRS, which under-
went restructuring last year into separate 
departments, is now to be further sepa-
rated into a loose consortium of distinct 
institutes. “They are keeping the name 
CNRS but will have transformed it into 
something that has nothing to do with 
it,” says Alain Trautmann, an immunolo-
gist at the Institut Cochin and founder 
and former spokesperson of Let’s Save 
Research. “A few years ago, the most 
important person was not the minister 
of research, but the director of CNRS. 
This is now becoming a structure that is 
no longer ruled by scientists. They want 
everything decided at the level of the 
ministry,” says Trautmann. “There are a 
few researchers who were consulted on 
an informal basis within networks that 
know the minister. This has all been very 
opaque and was not done in an open 
way with a scientific board where people 
know who is advising and what has been 
said,” says Trautmann. He and others 
have asked the current director of CNRS, 
Catherine Bréchignac, to resign claiming 
that she is not protecting the best inter-
ests of the organization. “She basically 
does what the government asks her to 
do. She knows she has been put there 
to do certain politics and she knows that 
the two previous people were fired before 
the end of the contracts over disagree-
ment with the government, so Catherine 
Bréchignac is carefully avoiding anything 
that would go against the will of the gov-
ernment,” says Trautmann. But Bréchig-
nac claims that the CNRS would not be 
weakened by this reorganization. “We are 
simply repositioning an institute. We are 
changing structures and putting in place 
research networks to better respond to 
the global research challenges and to 
have a more clear strategy to decide in 
which direction we want to go,” she told 
Cell in an interview.
The funds for research distributed 
by CNRS, and another major research 
organization INSERM (which supports 
biomedical research and is the French 
equivalent of the US National Institutes 
of Health), have decreased markedly 
since the launch of a new grant funding 
agency called ANR (Agence Nationale 
de la Recherche). ANR has been widely 
criticized by scientists for reducing the 
stature of CNRS and INSERM. ANR now 
hands out much of the funding that used 
to be distributed by CNRS and INSERM 
and supports about half of all life sci-
ences research. According to the latest 
figures, ANR has funded 4500 research 
projects with 3 billion euros over 5 years. 
In contrast to CNRS and INSERM, ANR 
does not have elected scientists on its 
governing board. “ANR distributes hun-
dreds of millions of euro and has no con-
sulting scientific board. That is surreal,” 
says Pierre Netter, a professor of genet-
ics at the Université Pierre et Marie Curie 
in Paris.
Grant Applications Change Course
ANR has instigated a new system, pilot-
age de recherche (call for proposals), in 
which the majority of submitted grants 
(~70%–75%) are allocated to research 
proposals that are in line with particu-
lar research fields, such as cancer or 
neurodegenerative disease. Only 25% 
of funding is available for so-called 
white programs (program blanc), which 
allow researchers to submit grants on 
any research topic, with funds awarded 
based on excellence rather than sub-
ject area. This disparity is perceived by 
researchers as too directed, threaten-
ing the independence of researchers 
used to a more bottom-up approach in 
which they initiate and develop their own 
research goals.
Echoing the sentiment of many 
French scientists, Saint-Jean calls the 
recent push on behalf of the govern-
ment to boost applied research through 
ANR-directed funding of specific topics 
“a bad idea.” “Some extremely innova-
tive research comes out of places where 
no one suspects it will come from. You 
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just don’t know where the next break-
through will emerge,” she says. “Knowl-
edge is something which you can value 
for itself. They don’t see that. According 
to the current political administration, 
research is something that must pro-
duce innovation, which must have some 
application, only that.” And Netter wor-
ries that advances in basic research with 
less direct application will fall behind. 
“All the new measures that are being put 
in place to distribute grants are favoring 
useful research, as if there were such a 
thing as useful and not useful research,” 
he says. “Richard Nixon had a set plan 
for finding a cure for cancer which 
resulted in nothing interesting. This was 
a mistake. There is no system that can 
predefine how breakthroughs will occur 
in science, especially in fundamental 
research.”
Jean-Francois Bach, an immunolo-
gist and the permanent secretary of the 
Académie de Sciences, says “Fund-
ing should be more open. We at the 
academy feel that the excellence of a 
project should be the only criterion and 
that most funding should be given to so-
called white schemes that are based on 
excellence independently of the topic.” 
Beraneck agrees: “We don’t know what 
is going to happen tomorrow. Every 
three months or so there is a new reform. 
Sometimes it is like every day,” he says. 
“We are not sure that the CNRS is going 
to exist, and we are not sure we can get 
a grant from ANR. They make the deci-
sions, they make the call for proposals, 
and you have to force research into a 
direction which falls into the mainstream 
projects they provide funding for.”
The government is the main employer 
of scientists in France, which does not 
have a tradition of private companies 
financing research. Saint-Jean believes 
that the French government’s current 
strategy of reorganizing publicly funded 
research toward more applied research 
is the wrong approach and that it should 
focus, rather, on increasing incentives 
for corporations to finance research and 
employ scientists. “Businesses are not 
financing research sufficiently in France 
and I don’t see that they will be doing 
that now in a time of crisis,” she says. 
“For the biomedical sector that might 
not pose any problems, but for all other 
areas it will.”
Valérie Pécresse, the Minister for 
Higher Education and Research, who 
is responsible for making decisions and 
implementation of reforms, agrees to the 
validity of the objections voiced by the 
scientific community and said in a writ-
ten statement to Cell that “the ANR must 
make room for more investigator-driven 
projects.” In what Pécresse referred to 
as “a show of faith towards the entire 
community,” she noted that she had 
already increased the share of fund-
ing for white program proposals, and 
that she “would like the share of these 
projects to reach 50% of the funding 
allocation.” In response to the concerns 
of the scientific community, Pécresse 
held a press conference in October to 
announce that white programs would 
indeed be increased to constitute 50% 
of the funds allocated by ANR starting in 
2010.
A New Alliance…
The increasing prominence of ANR 
and diminishing influence of CNRS and 
INSERM in funding research is not the 
only concern. The newly formed National 
Alliance for Life and Health Sciences has 
been viewed with skepticism by many in 
the scientific community. The Alliance—
combining eight institutes including 
CNRS, INSERM, the Institut Pasteur, 
and several agricultural, nutritional, and 
statistical institutes—was formed in 
response to a report by Elias Zerhouni, 
former director of the US National Insti-
tutes of Health. Zerhouni was invited by 
the French government to make recom-
mendations about the reorganization 
of its disparate biomedical institutions. 
Pécresse said in a written statement 
that the Alliance’s objective is to “form 
a very tight operational coordination for 
the implementation of measures and to 
achieve improved harmonization and 
simplification of procedures.”
Whether this new Alliance will truly 
remove some of the complexity of the 
current system remains to be seen. 
“Most of us agree that there are too many 
layers of administration, and most of us 
are convinced that this new Alliance is 
not going to improve research, but is 
just adding another layer of complexity,” 
says Claire Legay, a neurobiologist at the 
Université Paris-Descartes, whose lab is 
funded by INSERM. “The level of com-
plexity is really too high and the funding 
is very low. We don’t know who is going 
to fund what,” she says. “In the past, we 
used to have more time to do research, 
because we had money coming from 
the government more easily and didn’t 
have to stress all the time to find money 
through organizations like ANR.” French 
biologists also are concerned that the 
new Alliance will lead to biology becom-
ing cut off from other disciplines such 
as chemistry and physics, weakening 
cross-disciplinary research and slowing 
innovation.
…And a University Shake Up
Another component of the govern-
ment’s overhaul of the French research 
landscape has been to grant univer-
sities more autonomy, making them 
more like private organizations with 
less dependence on public financing 
and allowing them to shoulder more 
responsibility for the research con-
ducted in their labs. “The strategic path 
we have carved for the past two years 
was designed, first and foremost, to 
provide universities with the autonomy 
they needed to become major actors 
in research,” said Pécresse in a written 
statement. Twenty of the 81 public uni-
versities in France became autonomous 
on January 1st this year, and the next 
wave of 20 universities are expected to 
become autonomous on January 1st, 
2010. “In contrast to a US university, the 
president of a French university has two 
roles, and that is not good,” explains 
Netter. “There is the scientific academic 
part, and then the administrative and 
financial. In the US, these are separate 
roles. In France, both are performed 
by the president, giving him too much 
power,” he says.
Opponents of this reform, such as 
Trautmann, fear that the infrastruc-
ture will not be in place for universities 
to handle their newly added responsi-
bilities. “More than 10,000 researchers 
from CNRS will suddenly have to be 
[overseen], paid, administered by the 
universities and without the correspond-
ing staff this would be a real mess. It 
could be too much at once,” he says. 
But changes to the antiquated university 
research system are generally deemed 
as necessary by the scientific research 
community. “Globally speaking I think 
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the reform is needed. The system is 
not good enough. It is not competitive 
enough. The lack of competition makes 
the job less attractive. It is also not well 
considered in France and not well paid,” 
says Beraneck.
Universities, together with CNRS and 
INSERM, have traditionally formed the 
so-called “unités mixtes de recherche” 
(UMR), of which there are 400 across 
France. UMR labs are run partly by the 
universities and partly by CNRS and 
INSERM. The quality of research in UMR 
centers is considered better than that in 
university labs. Pécresse calls the UMR 
labs “the locus for cooperation” and has 
stated that the ministry “would now like 
to move towards a resolute simplification 
of their management,” as they are cur-
rently overseen by four different bodies 
with different funding and evaluation 
systems.
Some scientists fear that with all of the 
reforms underway the balance of power 
will shift away from these research 
units. “Most of the best research in 
France emerges from these labs,” says 
Saint-Jean, who remains skeptical that 
the new balance of power will be held 
equally by the universities and ANR. She 
believes that if CNRS and INSERM do 
eventually disappear, it would be to the 
advantage of ANR but not the universi-
ties and would result in a weakening of 
the quality of research emerging from 
UMR labs. Jean-Francois Bach would 
like to see more cohesion between all 
of the institutes to improve communica-
tion between ANR, CNRS, and INSERM. 
“They don’t talk to each other enough,” 
he says.
Postdocs Face an Uncertain Future
This year, 900 postdoc positions have 
been lost in universities and CNRS- 
and INSERM-funded research insti-
tutes, with a dramatic impact on young 
researchers and their future. The num-
ber of new permanent positions offered 
to young researchers at CNRS and 
INSERM institutes has decreased by 
25% this year, according to statistics 
released by the Ministry of Higher Edu-
cation and Research, and there will be 
30% fewer PhD degrees awarded by 
2017. “There are more people hoping 
that they will get permanent positions, 
but they know that there will be fewer. 
This is not good for the spirit in which 
they work. Some young people just quit 
after they get their PhD,” says Legay. 
“You can discuss the fact that we don’t 
want to give permanent positions before 
scientists have acquired a certain matu-
rity, which would be okay if we actually 
had the opportunities for postdocs,” 
she says.
But a lack of permanent positions is 
not the only problem. “In France, you 
can only get one or two-year contracts. 
Mine is one year and can be prolonged 
by another year. It is funded through the 
space agency CNES,” says Beraneck. 
“But it’s very difficult to start a collabora-
tion this way. There is no long-term per-
spective.” Lab directors usually employ 
postdocs on 18 month short-term 
contracts paid with general lab funds. 
According to French labor law, these 
contracts cannot be renewed, resulting 
in a constant turnover of postdocs.
Regarding the dire situation fac-
ing postdocs, Pécresse has stated 
that going forward “postdoctoral con-
tracts will be proper work contracts, in 
accordance with French labor law, and 
will provide full guarantees in terms of 
security and social benefits for employ-
ees and that public institutions can now 
sign three-year postdoctoral contracts, 
which will allow a young researcher to 
develop his or her project.” She also has 
pledged not to cut jobs in either universi-
ties or research institutes in 2010 or 2011. 
Despite these assurances, the French 
scientific community watches and waits.
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